They play a pivotal role in priming and activating tumor-specific T cell responses by processing and presenting tumor antigens via MHC class I and II molecules, thereby initiating cytotoxic CD8+ T cell and helper CD4+ T cell responses (Banchereau and Steinman, 1998; Hou et al., 2024). This evidence concerns the gene CD8A and neoplasm.